Bridging the Middle East Through Technology - BLT Presents Full-Spectrum Imaging Innovation at NYU Abu Dhabi

New York University Abu Dhabi (NYUAD) recently hosted a seminar and technical workshop featuring Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as BLT) , invited to present its cutting-edge AniView Phoenix100 Full-Spectrum In Vivo Imaging System.
The event highlighted BLT's latest imaging innovations and marked a significant step in the company's growing engagement with leading research institutions in the Middle East.

Expanding Vision — Exploring the Mysteries of Life

As BLT's flagship system, the AniView Phoenix offers non-invasive, full-spectrum fluorescence imaging from visible light to the second near-infrared window (NIR-II).
The system enables advanced applications in stem cell research, oncology, and drug screening. Its powerful NIR-II capabilities support visualization of microvascular networks, real-time surgical guidance, and metabolic imaging—helping researchers gain deeper insight into complex biological processes.

Driving Collaboration — Empowering the Next Frontier of Research

During the seminar, the BLT team delivered an in-depth presentation on full-spectrum in vivo imaging techniques and conducted hands-on instrument demonstrations, receiving enthusiastic feedback from NYUAD researchers.

The event fostered dynamic academic exchange, with participants exploring the potential of AniView Phoenix across diverse research projects.
The AniView Phoenix system will remain at NYUAD for several weeks, allowing researchers to conduct further exploration and experimentation.

BLT extends its sincere gratitude to NYUAD for the invitation and collaboration. We also extend our sincere appreciation to all the participating researchers for their insightful discussions and inspiring exchange of ideas.
This collaboration underscores BLT's commitment to advancing global scientific research and to building bridges across regions through technological innovation.